References
- Irwin RS et al: Managing cough as a defense mechanisms and as a symptom: a consensus panel report of the American College of Chest Physicians. Chest, 1998114(Suppl.):133S-181S https://doi.org/10.1378/chest.114.2_Supplement.133S
- YJ Jeon. Chronic cough. Kor J Med 2002;63:118-25
- Irwin RS, Madison JM: The diagnosis and treatment of cough. N Engl J Med 2000;343:1715-21 https://doi.org/10.1056/NEJM200012073432308
- Irwin RS, Madison JM: The persistently troublesome cough. Am J Resp Crit Care Med 2002;165:1469-74 https://doi.org/10.1164/rccm.2110097
- J Chang. Common cold. Kor J Med 1999;56:778-80
- J Chang. Chronic cough. J Kor Med Assoc 2002;45:1331-42 https://doi.org/10.5124/jkma.2002.45.11.1331
- J Chang. Cough. Kor J Med 2002;63(Suppl 2):S500-S512
- JH Yoon. Human nasal mucosa histology. In: IY Park, JH Yoon, JG Lee, IH Chung. Editors. Clinical Anatomy of Nose. 1st ed. Seoul: Academia 2001. p32-56
- Quraishi MS, Jones NS, Mason J. The rheology of nasal mucus: a review. Clin Otolaryngol 1998;23: 403-41 https://doi.org/10.1046/j.1365-2273.1998.00172.x
- Barnes PJ, Chung KF, Page CP. Inflammatory mediators of asthma: An update. Pharmacol Rev 1998;50:515-96
- van Ganse E, Kaufman L, Derde MO, et al. Effects of antihistamines in adult asthma: A meta-analysis of clinical trials. Eur Respir J 1997;10:2216-24 https://doi.org/10.1183/09031936.97.10102216
- Spector SL, Nicodemus CF, Corren J, et al. Comparison of the bronchodilatory effects of cetirizine, albuterol, and both together versus placebo in patients with mild-to-moderate asthma. J Allergy Clin Immunol 1995;96:174-81 https://doi.org/10.1016/S0091-6749(95)70005-6
- Busse WW, Middleton E, Storms W, et al. Corticosteroid- sparing effect of azelastine in the management of bronchial asthma. Am J Respir Crit Care Med 1996;153:122-7 https://doi.org/10.1164/ajrccm.153.1.8542104
- Poole PJ, Black PN. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2000;2:CD001287
- Poole PJ, Black PN. Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review. BMJ 2001;322:1271 https://doi.org/10.1136/bmj.322.7297.1271
- Barnes PJ. Chapter 11. Airway pharmacology. In: Murray JF, Nadel JA, Mason RJ, Boushey HA Jr. Textbook of Respiratory Medicine. 3rd ed. W.B. Saunders Co. 2000. pp. 267-296
- JH You. Diagnosis and treatment of acute bronchitis The role of antitussives and mucolytics. Med Observer 2005;280:27
- Scadding G, Mitchell D. Chapter 28. Rhinitis and Sinusitis. In: Albert RK, Spiro SG, Jett JR. Clinical Respiratory Medicine. 2nded. Mosby Co. 2004. p347
- Hosoe H, Kaise T, Ohmori K, Isohama Y, Kai H, Takahama K, Miyata T. Mucolytic and antitussive effects of erdosteine. J Pharm Pharmacol 1999;51: 95- 9-66 https://doi.org/10.1211/0022357991773230
- MY Oh. Chapter 2. Types and mechanisms of hypersensitivity. In: The Korean Academy of Asthma, Allergy and Clinical Immunology. Asthma and Allergic diseases. Koonja Publishing. 2002. pp. 13-16
- JH Yoon. Chapter 11. Mucus. In: The Korean Academy of Asthma, Allergy and Clinical Immunology. Asthma and Allergic diseases. Koonja Publishing. 2002. pp. 73-77
- Decramer M, Rutten-van Molken M, Dekhuijen PNR, Troosters T, van Herwaarden C, et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCHUS): a randomized placebo- controlled trial. Lancet. 2005;365:1552-60 https://doi.org/10.1016/S0140-6736(05)66456-2